His experience includes the following representations:

Securities Offerings

  • IPOs for several biotech companies, as well as many underwritten follow-on public offerings
  • Several biotech companies with their recent PIPE deals, RDOs, ATM and equity-line offerings
  • Several multinational pharma companies in connection with their strategic investments in US public companies
  • A medical device company in a reverse merger, now commonly referred to as an alternative public offering
  • Several funds in PIPEs and RDOs
  • Underwriters in a specialty pharma IPO

Mergers and Acquisitions

  • A private biotech company in its sale to a large pharma company for up to US$7 billion
  • Combination of a public biotech company client with private biotech and subsequent up-listing on stock exchange
  • An Italian specialty pharma company with its acquisition of a US public specialty pharma company
  • A public biotech company in its sale to strategic buyer
  • A public company in its sale to private equity firm
  • A public clinical research organization in several private acquisitions of e-clinical companies
  • A public clinical research organization in a public tender offer of a public EDC company
  • Multiple private tech and biotech companies in their critical sale transactions

Private Placements

  • Private tech and biotech companies with their successful angel and venture financings
  • Venture capital firms and other funds with their investments in tech and biotech companies
  • Pension funds with investments in private companies